Offering the most advanced clinical trials available close to home
OSF Breakthrough Treatment Center is where we offer access to cancer clinical trials. The center is an extension of the ongoing cancer research at OSF Cancer Institute. We participate in groundbreaking trials, advancing cancer detection and curability technologies.
Our world-class care teams, led by top physicians, use the most promising technologies and research from around the globe to offer hope when traditional therapies fall short.
We collaborate with Origin, a partnership of top research centers and experts who work together to bring the best new medical treatments to those who need them most.
We offer swift access to promising global cancer therapies for both adults and children. Your care team works closely with other providers within the OSF health system, so your care journey is seamless.
In addition to pioneering research in many types of cancer, OSF was selected to become a member of the Gynecologic Oncology Group (GOG), which offers patients access to advanced and innovative treatments.
If you are interested in participating in a clinical trial, please complete this request form, or call 1-844-OSF-4-HOPE (1-844-673-4467).
Our team is available Monday-Friday from 8 a.m. to 4:30 p.m.
In its first year, the OSF Breakthrough Treatment Center became one of only 10 sites in the world to pioneer a new National Institutes of Health (NIH) study for pancreatic cancer detection. This blood test uses special biomarkers to create a unique RNA fingerprint, helping us catch diseases or their return early on.
The OSF Breakthrough Treatment Center is enrolled in a groundbreaking lung cancer early detection trial. We’re the second site in the world chosen to provide a method for easy mass-produced lung cancer screenings which can detect lung cancer earlier than ever before.
We’re exploring new ways to treat brain cancer using artificial intelligence, find ovarian cancer early in a groundbreaking way, study advanced molecular tumor profiling, develop treatments for glioblastoma and ovarian cancer and create new technologies to detect multiple diseases early on.